vs
Side-by-side financial comparison of AGENUS INC (AGEN) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $34.2M, roughly 1.5× AGENUS INC). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -31.0%, a 25.9% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -14.2%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs 5.6%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
AGEN vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $50.3M |
| Net Profit | $-10.6M | $-2.6M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | -1.9% |
| Net Margin | -31.0% | -5.1% |
| Revenue YoY | 27.5% | -14.2% |
| Net Profit YoY | 77.3% | -14.5% |
| EPS (diluted) | $0.09 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $50.3M | ||
| Q3 25 | $30.2M | $52.2M | ||
| Q2 25 | $25.7M | $60.4M | ||
| Q1 25 | $24.1M | $40.2M | ||
| Q4 24 | $26.8M | $58.6M | ||
| Q3 24 | $25.1M | $60.1M | ||
| Q2 24 | $23.5M | $46.8M | ||
| Q1 24 | $28.0M | $45.1M |
| Q4 25 | $-10.6M | $-2.6M | ||
| Q3 25 | $63.9M | $-4.2M | ||
| Q2 25 | $-30.0M | $-2.7M | ||
| Q1 25 | $-26.4M | $-4.8M | ||
| Q4 24 | $-46.8M | $-2.2M | ||
| Q3 24 | $-67.2M | $-7.0M | ||
| Q2 24 | $-54.8M | $-12.8M | ||
| Q1 24 | $-63.5M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
| Q4 25 | 42.1% | -1.9% | ||
| Q3 25 | -15.0% | -0.6% | ||
| Q2 25 | -65.0% | 4.8% | ||
| Q1 25 | -55.3% | -17.2% | ||
| Q4 24 | -96.5% | 2.6% | ||
| Q3 24 | -125.5% | -0.6% | ||
| Q2 24 | -128.4% | -16.4% | ||
| Q1 24 | -117.4% | -16.7% |
| Q4 25 | -31.0% | -5.1% | ||
| Q3 25 | 211.4% | -8.0% | ||
| Q2 25 | -116.8% | -4.4% | ||
| Q1 25 | -109.6% | -11.8% | ||
| Q4 24 | -174.4% | -3.8% | ||
| Q3 24 | -267.7% | -11.7% | ||
| Q2 24 | -233.1% | -27.4% | ||
| Q1 24 | -226.6% | -29.4% |
| Q4 25 | $0.09 | $-0.11 | ||
| Q3 25 | $1.94 | $-0.18 | ||
| Q2 25 | $-1.00 | $-0.12 | ||
| Q1 25 | $-1.03 | $-0.21 | ||
| Q4 24 | $-1.95 | $-0.11 | ||
| Q3 24 | $-3.08 | $-0.31 | ||
| Q2 24 | $-2.52 | $-0.57 | ||
| Q1 24 | $-3.04 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $10.5M |
| Total DebtLower is stronger | $44.7M | $185.1M |
| Stockholders' EquityBook value | $-271.1M | $-18.2M |
| Total Assets | $226.8M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $10.5M | ||
| Q3 25 | $3.5M | $8.1M | ||
| Q2 25 | $9.5M | $9.1M | ||
| Q1 25 | $18.5M | $5.9M | ||
| Q4 24 | $40.4M | $12.4M | ||
| Q3 24 | $44.8M | $10.1M | ||
| Q2 24 | $93.7M | $9.3M | ||
| Q1 24 | $52.9M | $7.5M |
| Q4 25 | $44.7M | $185.1M | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $-18.2M | ||
| Q3 25 | $-274.1M | $-12.1M | ||
| Q2 25 | $-354.6M | $-7.7M | ||
| Q1 25 | $-341.8M | $-8.1M | ||
| Q4 24 | $-326.4M | $-4.4M | ||
| Q3 24 | $-292.3M | $1.6M | ||
| Q2 24 | $-241.3M | $6.5M | ||
| Q1 24 | $-201.4M | $18.0M |
| Q4 25 | $226.8M | $434.9M | ||
| Q3 25 | $233.9M | $435.2M | ||
| Q2 25 | $185.2M | $438.1M | ||
| Q1 25 | $200.2M | $441.0M | ||
| Q4 24 | $226.3M | $471.0M | ||
| Q3 24 | $238.5M | $495.7M | ||
| Q2 24 | $292.4M | $494.9M | ||
| Q1 24 | $256.6M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $4.3M |
| Free Cash FlowOCF − Capex | — | $4.1M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $4.3M | ||
| Q3 25 | $-14.7M | $295.0K | ||
| Q2 25 | $-20.2M | $1.6M | ||
| Q1 25 | $-25.6M | $-7.7M | ||
| Q4 24 | $-28.7M | $8.0M | ||
| Q3 24 | $-53.3M | $1.3M | ||
| Q2 24 | $-38.2M | $-10.4M | ||
| Q1 24 | $-38.2M | $-2.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | $-20.2M | $1.2M | ||
| Q1 25 | $-25.6M | $-8.0M | ||
| Q4 24 | $-28.7M | $7.0M | ||
| Q3 24 | $-53.3M | $-1.1M | ||
| Q2 24 | $-38.6M | $-10.6M | ||
| Q1 24 | $-38.2M | $-4.7M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | -78.7% | 1.9% | ||
| Q1 25 | -106.5% | -19.8% | ||
| Q4 24 | -107.0% | 12.0% | ||
| Q3 24 | -212.2% | -1.8% | ||
| Q2 24 | -164.4% | -22.7% | ||
| Q1 24 | -136.5% | -10.4% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.3% | 1.7% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 2.0% | 0.5% | ||
| Q1 24 | 0.1% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
